Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
The Art of Creating a Physician Peer Review Panel: Contracting and Training
This article is the second in a two-part series about best practices for building a physician peer review panel.
Mitchell
News Release
Mitchell Issues First Quarter 2019 Industry Trends Report
San Diego, CA—March 12, 2019—Mitchell, a leading provider of technology, connectivity and information solutions t
Mitchell
News Release
Empower Your Customers and Appraisers with Photo-Based Estimating
The introduction of photo-based estimating brings insurance carriers great benefits such as increased efficiency and cost-effective resource manage
Workers' Comp
Article
StateWatch: Bill Review February/March 2019
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
How Diagnostics Improve the Auto Insurance Claim Process
Fifty years ago all that you needed to fix a dented vehicle was a hammer and dolly. Flash-forward to today.
Workers' Comp
Podcast
Demystifying the MSA